一种可诱导增强病原特异性T细胞反应的疫苗及其组成

Vaccine composition for inducing enhanced pathogen antigen-specific T cell responses, comprises immunogenic protein comprising antigen of pathogen, saponin-base adjuvant, and toll-like receptor (TLR) agonist adjuvant

点击次数:456   下载次数:280
中文摘要:本发明公开了一种可诱导增强病原特异性T细胞反应的疫苗及其组成,其特征是包含以下成分:(1)达到一定治疗剂量的免疫原蛋白,该蛋白由一种病原的抗原组成;(2)皂角免疫佐剂,如GPI-0100、Quil A或QS-21;(3)TOLL样受体(TLR)激动剂佐剂,如单磷酰酯A或胞嘧啶-磷酸盐-鸟嘌呤-1826。该疫苗可诱导增强肺炎支原体等病原的抗原特异性T细胞反应。
外文摘要:NOVELTY - Vaccine composition comprises: (a) a therapeutic amount of an immunogenic protein comprising an antigen of a pathogen; (b) a saponin-base adjuvant selected from GPI-0100, Quil A, and QS-21; and (c) a toll-like receptor (TLR) agonist adjuvant selected from monophosphoryl lipid A (MPL), and cytosine-phosphate-guanine (CpG)-1826.
申请号:US2016250324A1
公开/公告号:2016.09.01
申请日:2016-02-24
公开/公告日:2016-11-22
申请/专利权人:THEVAX GENETICS VACCINE CO LTD (THEV-N)
发明/设计人:WU, C;WU, J;CHIU, Y;等
点击下载:一种可诱导增强病原特异性T细胞反应的疫苗及其组成
  1. 编译服务:动物支原体学
  2. 编译者:程金花
  3. 编译时间:2016-10-24